BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma Peptide Research Overview Mechanisms, Applications & Insights The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Can GHK Cu Be Taken Orally? Oral GHK Cu Bioavailability, Tablets & Copper Peptide Safety Neurogan Health